Literature DB >> 1723805

Neurogenic function of the diabetic rat bladder: alteration by calcium channel effectors.

J A Belis1, R M Curley, C H Wagner, V N Murty, S J Winter, T J Rohner.   

Abstract

The in vitro effects of a calcium channel antagonist (nifedipine) and agonist (BAY K8644) on the neurogenic responses of the streptozotocin-induced diabetic rat bladder were investigated. The bladder body and bladder base were studied separately. There were no significant differences in neurogenic responses in diabetic bladder body compared to control body, but the diabetic bladder base demonstrated an increased contractile response at each frequency compared to control base. The rate of contractile response was similar in controls and diabetics but was significantly different between body and base. Although declining with time, contractile responses in the diabetic bladder body and base were increased from control in the absence of extracellular calcium. Differences were found in effects upon maximum responses between diabetic and control tissues treated with nifedipine and BAY K8644. BAY K8644 did not completely reverse the effect of nifedipine on the neurogenic responses in the diabetic bladder body. Effects of diabetes on the bladder body and base are associated with changes in calcium channel activity of bladder smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723805     DOI: 10.1159/000138855

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

1.  The Inhibitory Mechanism on Acetylcholine-Induced Contraction of Bladder Smooth Muscle in the Streptozotocin-Induced Diabetic Rat.

Authors:  Jong Soo Han; Su Jin Kim; Yoonjin Nam; Hak Yeong Lee; Geon Min Kim; Dong Min Kim; Uy Dong Sohn
Journal:  Biomol Ther (Seoul)       Date:  2019-01-01       Impact factor: 4.634

2.  The change of signaling pathway on the electrical stimulated contraction in streptozotocin-induced bladder dysfunction of rats.

Authors:  Jong Soo Han; Young Sil Min; Gil Hyung Kim; Sang-Hyun Chae; Yoonjin Nam; Jaehwi Lee; Seok-Yong Lee; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.